Rankings
▼
Calendar
IINN (Inspira Technologies Oxy B.H.N. Ltd.) Stock Financials & Earnings | Market Cap Arena
IINN
Inspira Technologies Oxy B.H.N. Ltd.
Mkt Cap
$14M
Healthcare
·
Medical - Devices
·
🇮🇱 Israel
·
NASDAQ
Revenue (TTM)
$289,000
Net Income (TTM)
-$13M
EPS (TTM)
-$0.62
Free Cash Flow (TTM)
$0
Gross Margin
0.7%
Op. Margin
4512.5%
Net Margin
-4373.0%
FCF Margin
0.0%
P/S Ratio (TTM)
47.5x
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q2 2025
Browse All Reports
Next: Q3 2025 · Apr 1
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 22
$0
$0
$816K
Q2 22
$0
$0
-$4M
Q3 22
$0
$0
-$4M
Q4 22
-$5M
-$5M
-$3M
Q1 23
$0
$0
-$3M
Q2 23
$0
$0
-$3M
Q3 23
$0
$0
-$3M
Q4 23
$0
$0
-$3M
Q1 24
$0
$0
$3M
Q2 24
$0
$0
$3M
Q1 25
$145K
$1K
$4M
Q2 25
$145K
$1K
$4M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 22
—
—
Q2 22
—
—
Q3 22
—
—
Q4 22
—
—
Q1 23
—
—
Q2 23
—
—
Q3 23
—
—
Q4 23
—
—
Q1 24
—
—
Q2 24
—
—
Q1 25
95.0x
—
Q2 25
47.5x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 22
$0
$0
Q2 22
$3K
$3K
Q3 22
$0
$0
Q4 22
-$1M
-$2M
Q1 23
$0
$0
Q2 23
$1K
$1K
Q3 23
$0
$0
Q4 23
$0
$0
Q1 24
$0
$0
Q2 24
$0
$0
Q1 25
$0
$0
Q2 25
$0
$0
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 22
$0
Q2 22
$0
Q3 22
$0
Q4 22
$172K
Q1 23
$0
Q2 23
$0
Q3 23
$0
Q4 23
$0
Q1 24
$0
Q2 24
$0
Q1 25
$0
Q2 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 22
—
-150.4%
Q2 22
—
+371.4%
Q3 22
—
+22.5%
Q4 22
—
-119.2%
Q1 23
—
+502.8%
Q2 23
—
-31.2%
Q3 23
—
-26.7%
Q4 23
+100.0%
+307.5%
Q1 24
—
-188.3%
Q2 24
—
-195.2%
Q1 25
—
-231.5%
Q2 25
—
-210.0%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 22
$0
—
Q2 22
$3K
—
Q3 22
$0
—
Q4 22
$5K
—
Q1 23
$0
—
Q2 23
$1K
—
Q3 23
$0
—
Q4 23
$1K
—
Q1 24
$0
—
Q2 24
$0
—
Q1 25
$0
0.0%
Q2 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 22
$2M
$2M
$472K
Q2 22
$3M
$1M
$305K
Q3 22
$2M
$1M
$301K
Q4 22
$2M
$1M
$247K
Q1 23
$2M
$1M
$168K
Q2 23
$2M
$1M
$233K
Q3 23
$2M
$907K
$193K
Q4 23
$2M
$681K
$152K
Q1 24
$2M
$1M
$175K
Q2 24
$2M
$1M
$175K
Q1 25
$2M
$2M
$221K
Q2 25
$2M
$2M
$221K
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q2 22
$14M
$5M
$19M
Q3 22
$6M
$10M
$16M
Q4 22
$7M
$7M
$14M
Q1 23
$6M
$5M
$11M
Q2 23
$3M
$6M
$9M
Q3 23
$3M
$3M
$6M
Q4 23
$5M
$2M
$7M
Q1 24
$0
$0
$0
Q2 24
$4M
$0
$4M
Q4 24
$5M
$668K
$6M
Q1 25
$2M
$0
$2M
Q2 25
$2M
$0
$2M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 22
11M
+0.0%
Q2 22
11M
+4.0%
Q3 22
11M
+0.0%
Q4 22
11M
+0.5%
Q1 23
12M
+5.0%
Q2 23
12M
+2.5%
Q3 23
12M
-2.4%
Q4 23
16M
+33.8%
Q1 24
17M
+6.2%
Q2 24
17M
+0.0%
Q1 25
27M
+61.1%
Q2 25
27M
+0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
—
—
FY 21
$0
21
FY 22
-$123K
38
FY 23
$0
37
FY 24
$0
38
marketcaparena.com